Company news
Innovotech Inc. (TSXV:IOT) news
Innovotech Inc. news releases on 6ix. Latest, Aug 18, 2026: Innovotech Inc. Reports Q2 2026 Financial Results
Press releases & updates
Innovotech Inc. Reports Q2 2026 Financial Results
August 18, 2026
Innovotech Inc. Launches of InnovoTEST(TM) Hazardous Drug Wipe Testing Kits to Support Pharmacy Compliance and Healthcare Worker Safety
August 13, 2026
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
Innovotech Inc. to Present at the Life Sciences Investor Forum on June 25th
June 24, 2026
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
Innovotech Inc. Announces CFO Transition and Reports 2026 Annual General Meeting Result
June 16, 2026
Innovotech Inc. Receives Support to Develop Antimicrobial Testing Services and Product Enhancements
May 13, 2026
Innovotech Inc. Reports Q1 2026 Financial Results and Operational Update
May 12, 2026
FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program
April 29, 2026
Innovotech Inc. Begins Trading on OTCQB Under Symbol IOTCF, Expanding Access for U.S. Investors
April 14, 2026
Innovotech Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
March 31, 2026
Innovotech Inc. Strengthens Executive Team and Announces New Edmonton Facility Lease
February 5, 2026
Innovotech Inc. Announces Intention to Apply for Trading on the OTCQB Venture Market
January 26, 2026
Innovotech Inc. Presenting at the 3rd Annual DealFlow Discovery Conference
January 26, 2026
Innovotech Inc. Announces Amalgamation of Subsidiaries to Streamline Operations
January 2, 2026
Innovotech Inc. Reports Record Revenue for Its Third Quarter
November 4, 2025
Innovotech Inc. Reports Record Revenue For Its Third Quarter.
November 4, 2025
Innovotech makes strategic investments to expand analytical laboratory services and offers an unsecured convertible debenture for $200,000.
October 15, 2025
Innovotech Expands Fractional CFO Agreement and Occupies New Office and Lab Space
October 6, 2025
Innovotech Inc. Reports Results For Its Second Quarter And Half-Year Ended 30 June 2025
August 19, 2025
Innovotech Inc. Grants Director's Options Subsequent to the Annual Meeting
July 10, 2025
Innovotech Inc. Receives US$402,926 Following Exit from its Position in a Canadian Private Company
July 8, 2025
Innovotech Inc. Announces Annual General and Special Meeting Results, New Director and Corporate Changes
July 8, 2025
Innovotech Inc. Reports Record Revenue for Q1-2025.
May 13, 2025
Innovotech Receives Support to Develop Antimicrobial Testing Services and Product Enhancements
May 8, 2025
Innovotech Achieves Record Annual Revenue and Positive Net Income for 2024
April 16, 2025
Innovotech Inc. Expands Lab Space and Staff to Meet its 2025 Contract Research Pipeline
February 3, 2025
Innovotech Inc. Appoints Mr. Brad Clark, CPA, CBV to its Board of Directors and Creates New Operating Subsidiary to Prepare for Growth.
January 13, 2025
Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices
January 7, 2025
Innovotech Reports Results For Its Third Quarter And Nine Months Ended 30 September 2024
November 19, 2024
Innovotech Inc. Closes Over-subscribed Private Placement and Completes the Acquisition of Keystone Labs Inc.
November 5, 2024
Innovotech Inc. Announces Update to Keystone Acquisition and Private Placement
October 30, 2024
Innovotech Inc. signs Definitive Agreement to acquire Keystone Labs Inc.
October 21, 2024
Canadian Investment Regulatory Organization Trade Resumption - IOT
September 11, 2024
Innovotech Inc. signs non-binding Letter of Intent to acquire Keystone Labs Inc. and announces a non-brokered private placement
September 11, 2024
Innovotech Reports Results for its Second Quarter and Half-Year Ended 30 June 2024
August 20, 2024
Innovotech Announces Annual General and Special Meeting Results
July 16, 2024
InnovoSIL-1 Antimicrobial Silver Shown to Kill COVID-19, Norovirus and Other Medically Important Viruses
June 18, 2024
Innovotech Reports Results for its First Quarter Ended 31 March 2024
May 21, 2024
Innovotech Reports A Loss For Fiscal 2023
April 24, 2024
Innovotech appoints Bernard Grobbelaar as Chief Financial Officer
December 12, 2023
Innovotech Reports Results for its Third Quarter Ended 30 September 2023
November 28, 2023
Innovotech awarded $300,000 in grant funding to develop InnovoSIL-1 Antimicrobial Silver
November 28, 2023
Innovotech Inc. Announces Annual General and Special Meeting Results
October 11, 2023
Innovotech Closes Majority Stake in Nou Life Skincare Technology
August 25, 2023
TSX Venture Exchange Stock Maintenance Bulletins
August 22, 2023
Innovotech Reports a Profitable Second Quarter Ended June 30th, 2023
August 15, 2023
Notice of Grant of Third Party Option by Control Person
August 1, 2023
Innovotech Appoints Julie Wright to its Board of Directors
July 17, 2023
Innovotech Appoints Dr. Craig Milne as Chief Executive Officer
July 17, 2023